Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I had a bid in but nobody was willing to sell today. I guess that could be because everybody holding likes the business plan as well as the ceo behind it.
NORML Canada National Conference: John Conroy, John Fowler , Rielle Capler & Mark Gobuty
I guess this is a bit old from last spring, but I hadn't seen it yet.
Informative as to the issues being faced in the sector many of us are speculating in.
I like the fact that Fowler is working to advance the industry as a whole. Good man to have at the helm imo.
Part 1
Oh, I don't know. Not much different than all the nuclear submarines out there. Just run a long extension cord... :)
http://newsoffice.mit.edu/2014/floating-nuclear-plants-could-ride-out-tsunamis-0416
(co-author is with cbi)
There are more similar articles. about cbi is decommsioning an old Russian one - as article mentions, the basic concept isn't that new...
I could have sworn I saw another mentioning a French nucler co., probably should have bookmarked it. we can see that cbi is involved somewhat with the tech, anyway .
They would build the structure but a reactor outfit would build the guts, was the gist I got...
Only here for a look as this is being pumped on at least one of the MJ boards as a hemp play...
What? No hemp?
But they got a contract to sell sugar to Kyrgyzstan... LOL
I am so tempted to say something..
Don't want to sound too cynical here, but, speaking as a languishing investor in hreef, all I can say is I hope they know to break the sugar into small shipments and then ask for Cash on Delivery each time, otherwise there's a good chance they will never get paid. As for recourse through litigation, I don't think Kyrgyzstan has too many foreign assets left that haven't alreaady been frozen, subject to seizure for breach of contract.
Actually. if they have expertise in making deals work with problematic countries, that represents an underserved market, so they could do well with that sort of thing...
Should have said few weeks I guess. hmm, just checked. OK, 6 weeks then, based on the last one. I can still wait. Was planning on giving them another quarter anyway, depending.
The next quarterly financials are due to come out over the next couple weeks or so. I can wait until then.
I think I see it. Just added. Just missed the bottom, but close.
Uranium spot price is up. Hard to say why uran started uptrend in June just as oil started diving... A bit of a dip at the moment looks like around $36, down from recent $40 but way up from $27...
Japanese reactors coming back on line. Lots of reactors around going to need refueling. Supply glut going to be worked down. They can't convert to oil even though oil is cheap. They have to use uranium. I agree this is going to go up.
I saw an interesting article about cbi and a French nuclear firm possibly collaborating (someday) on floating reactors that would be moored off coastlines. They would be very safe because the main cause of breaches, failure of cooling would be overcome by being surrounded by water. Also, any breach of matter would be quickly diluted to safe levels. The design is such it would just bob around up and down if there was a tsunami or I think it could also submerge to avoid extreme storms. A ways off time-wise but it would constitute nuclear as safe and non-greenhouse gas emitting, etc. Nuclear is going to stay viable for energy.
OK, so, not dead after all...
Surrey, BC — (November 17, 2014) —Global Hemp Group Announces Convertible Debenture Financing
http://globalhempgroup.com/global-hemp-group-announces-convertible-debenture-financing/
OK so they got some money. Not too bad terms, deferred interest. 0.05 and 0.035 coversion price. Now what to do with the money? South Africa, eh? Well that's pretty global and it isn't winter there...
Surrey, BC — (December 29, 2014) —Global Hemp Group Signs Letter of Intent to Acquire 50% Interest In House of Hemp
http://globalhempgroup.com/global-hemp-group-signs-letter-of-intent-to-acquire-50-interest-in-house-of-hemp/
I agree. There has been some feather ruffling going on with their, shall we say, nemesis, at the moment, but I find myself favoring their side, so far...
Niobium and REE's? Sweet!
An earthquake? Doesn't seem like that would be considered a suitable thing for praying. I think it's only supposed to be for good things. The people in Brazil seem nice enough, wouldn't want anything bad to happen to any of them. Besides, it could backfire. Depending on where one is in the tangle of human belief systems, one might want to be wary of generating bad karma or something.
Here's what I think. High currency inflation in Brazil means that internal prices for everything including mining equipment and labor is going to go up. Also, the government in Brazil is probably the major contributer to their problem, because, like pretty much all governments, including our own, they will have a tendancy to overspend. The typical solution of sorts, with floating currencies, is to monetize the debt and inflate your way out of it. Until inflation starts to get out of hand. Then they have to look at either austerity (yeah, right) or increasing revenues. Now, they're going to start looking around for a pile of money they can raid that won't have a lot of negative political impact with the general population.
It wouldn't surprise me if they followed Mexico's example and came up with a "special" 15% (or so) tax,out of the blue, on mining. CBMM, big as they are with market share, have a lot of power to dictate price. Naturally, they will pass the cost increases on to the customer. The customers will pay because it still isn't a major cost of steel production for the benefits it bestows. That puts us in a good relative position around the time we are ready to go into production. Meanwhile, with the bear market in resources (except niobium!), a lot of spare capacity is idle looking for project work. Building and finishing the mine can be done faster and cheaper than when everything was booming.
See? Nothing to worry about. :)
I believe all you need is to get one MM interested enough to make a market for a particular ADR. We seem to have several at this point...
The bid and ask seem to update presumably ok with dollar translation off the main exchange but the much lower volume has made it difficult to get a fill at anything in between.
Dec 31, 2014 - Ebola in Britain: Infected nurse Pauline Cafferkey treated with survivors blood and experimental drugs
[...] "Dr Jacobs said the hospital was unable to obtain ZMapp, the drug used to treat fellow British volunteer nurse William Pooley, who recovered, because "there is none in the world at the moment". [...]
http://thetruth24.com/article/73556/ebola-in-britain-infected-nurse-pauline-cafferkey-treated-with-survivors-blood-and-experimental-drugs
Yeah, this is all taking way much longer than I initially hoped.
We've kind of gone full circle. Share price is now back to where it was when I started my position, before all the controversy erupted.
Definitely need more ZMapp... A lot more. ASAP
I don't see that on their web site yet...
Does this mean that they are setting up shop elsewhere?
as per a recent pr (on their website)
[...]"The Company’s main focus now is to secure the US$ 118 million arbitration award in Canadian courts and to diversify its operations to more business friendly jurisdictions.” [...]
looks like short covering where they reload for the next periodic artificial push down.
the only counter is to load the bid which compels them to step in front of you a little higher on the bid to cover...
I think that we will see more covering as opposed to dumping and hopefully less bad talking to simultaneously try to pry shares loose near the all time low as we near the next revenues / sales announcement. There were a couple of huge blocks recently that looked like some final maneuver positioning.
after they move on, then it's safer to buy (real) shares on the ask when it's not flooded with short pseudo shares. otherwise, buying on the ask (and selling on the bid) just tends to feed the beast... jmho
Theralase is good because they won't likely face competition. I have previously checked out the ticker you mention and they seem to have something that is pretty good, however, although they may enjoy some success near and medium term success, they face getting blown out of the water at some point by an even better, I would say disruptive technological development I came across recently in the same bio-testing area.
If I had time I guess I could go into more detail on that board. Ok, I don't want to leave you hanging either...
You might find this extremely interesting as I did.
Harvard University’s Wyss Institute for Biologically Inspired Engineering
http://www.digitaltrends.com/cool-tech/slip-paper-can-detect-ebola-virus-less-hour/?utm_source=o1&utm_medium=cpc&utm_campaign=o1
Unfortunately, in regard to active trading appeal, the research is being sponsored by a multi-billion dollar investment-grade corporation (Agilent) and while it is likely that they will incorporate it into their existing bio-testing area someday, it isn't very investable from the upside potential aspect of a pure-play like Theralase. I have little doubt Agilent would be a good place for a passive investment but because it is only a portion of their business, it probable won't have a major effect on their share price. At least not for a long time, despite the fact that the tech invention is pretty awesome. I intend to keep an eye on it though in case they somehow spin it off or it goes as a separate entity ipo, in which case it would be an awesome play.
re: "I would love to find another company like Theralase in 2015.. "
There seems to be a bias in medicine towards, well, medicine, which is to say, pharmacology. One could identify two major camps, if you will, medical doctors that look to administer pills and injections, or surgeons. Surgeons have been more receptive to new devices, like robotic aids, because they are used to using tools to begin with. The Theralase device has merit, obviously, but will face an uphill battle for a while because, I think, it is overlapping, or kind of infringing on the pills and liquids as treatment convention. Fortuneately, Theralase should have appeal and get some support from surgeons since it has a surgical aspect.
Since you asked, and I hope there isn't a total ban on at least mentioning other tickers, otherwise I might never have found out about Theralase... It's a good idea not to put all of ones eggs in one basket, after all. Promising new devices represent an area for future growth and so have been looking around for similar plays as well. There are a lot of them around but most of them seem pretty iffy to me. So have striven to narrow things down in my research, such as it is... My other holding in this area is aemd which is facing a lot more bias, since it is a more purely medical device, but also has been proven to cure previously uncurable diseases so, like Therelase, I have some confidence it will eventually move ahead from this early stage and gain acceptance as its merits continue to be proved out. Suggest check it out as appears we are around a good entry point in the stage of developments as well.
Despite some of the absurd misinformation being posted recently targeting Affinor...
Abattis seems like the outfit that would be difficult to work for or otherwise try to have dealings with...
Looks more like "Goodbye Abattis " now. :)
Good riddance.
I also saw a blurb about a suspected case in Japan now...
I'm guessing it has something to do with psychology. :)
Ah, well. Obviously there is going to be some competition, and Europeans are going to tend toward a European product. I think it is sufficient to say that SIMH is going to see a big increase in revs for the foreseeable future since they are well positioned in the American market, which is pretty huge.
I already used "usaid" with "thermometer" - yahoo search before to find the previous. "usaid" by itself with google chrome gets you about a million non-relevent hits. With "ebola" - still get a lot but found one relevent one here among the many:
hmm as of oct 15, 2014 actually looks like only about 200 (french?) thermometers got shipped.
WEST AFRICA - EBOLA OUTBREAK - FACT SHEET #3 (FY 15)
October 15, 2014
[...] "USAID/OFDA airlifted commodities—including 11,000 meters of barrier fencing, 200 infrared thermometers, 500 backpack sprayers, and 30 tents—arrived in Monrovia, Liberia, on October 10 to support EVD response activities throughout the country.[...]"
http://www.usaid.gov/ebola/fy15/fs03
It all depends on what you think the price of oil (&gas) is going to do.
I was lucky to get out in time the last time I had some of this.
It's starting to look real attractively cheap now, isn't it? But like you, I just don't know. I think they said they had 40,000 boe hedged at $84 which would get them through 1 qtr, but if oil stays 60 or below for a prolonged period...
GBHPF monthly progress report.
http://cnsx.ca/cmsAssets/docs/Filings/2014/2014_12_05_12_16_42_GHG_November_2014_Progress_Report.pdf
Well, they got some money, I guess to keep the lights on.
"Mikhail Gurfinkle and Sandy Janda resigned as board members. Curt Huber was appointed to the board of directors and Chairman of the Audit Committee."
Not going to be able to do anything with this stock either way until we get some volume. The spread is ridiculous. Pretty dormant. Board members losing interest. Hopefully they can turn over some of the hemp seed the farmers grew,
Well, it is winter. End of the year.
I still like it better than the nebulous financials and dealings of HEMP, which seems to have some kind of irrational cult following, though that at least has had volume, probably mostly due day traders. GBHPF seems more on the level, but slow going without the power of fluff.
Hemp seed should have a more ready market than fiber since it is both a food and fuel, if the market can be reached. Oh well, time will tell.
Agreed.
They look ready and a cinch to pass. But it seems HC likes to take their sweet time, which is beyond anyone's (outside of HC's) control.
I expect the stock will start to perk up nicely once the license is granted.
Where did you get your info? The only link I found so far is from Aug 2014. 100,000 hazmat suits was mentioned but they had only recieved 30k thus far. Also the mention of thermometers was grouped in with other equipment and supplies. Since the suits are disposable, I don't think you can assume a one for one correspondance.
https://www.devex.com/news/how-usaid-is-responding-to-ebola-in-west-africa-84181
[...]"USAID’s Ebola DART team was responsible for assessing emergency needs and managing a coordinated U.S. interagency response, and they were laying the groundwork for a possible scaling up of the response effort. The agency had so far committed 100,000 personal protective equipment suits — 30,000 of which had arrived. That’s in addition to gloves, buckets, body bags, infrared thermometers and other supplies, which the team was airlifting in to supply public health workers in the three affected countries"[...]
As of Nov. 18th 2014 it still doesn't look like they were actually getting enough of actual delivered.
https://www.devex.com/news/how-innovative-financing-can-help-prevent-the-spread-of-ebola-84869
[...]“We need more doctors and nurses. More beds and more treatment facilities. More personal protective equipment. More burial teams and more ambulances. More cell phones. More SIM cards. More motorbikes and trucks and helicopters. More plastic gloves, more bleach and more thermometers. And the list goes on and on.”
These were the haunting words of U.S. Ambassador to the United Nations Samantha Power, speaking in Geneva recently about the global response to the Ebola outbreak." [...]
SIMH had about 2000 in inventory on hand when the surge in demand came and cited a $500k backlog in Nov. on top of that. It seems likely the French supplier only kept a few thousand on hand as well.
BTW - what French supplier -- link?
fwiw I notice the "negative" IBIO rating on scotts "second opinion" research flag field is gone. The consensus of those particular analysts is now upgraded to "hold". Which is a kind of dumb thing about this type of rating system, because if one had followed the previous dumb rating and sold, there wouldn't be anything to hold, now would there. :)
Anyway, it looks like the lawsuits have evaporated, as expected. That will lift a weight off and make it more likely for future potential investors to take a new look at the stock.
um, what is that? How about a link to something in english?
Or a translation...
edit - jumped the gun... oh, i see you did. thanks :)
These guys know a lot about steel and make a lot of it. In addition to what looks like every other kind hmm includes Performance and Alloy steels. This is great having them on board.
They're a spinoff of Timken Bearing. Timken tapered roller bearings have been an industry standard over decades. "Timken" is the industry equivalent of a household name like "Kleenex".
Nice website too. Well, they are a blue-chip level co.
http://www.timkensteel.com/
re: the lawsuits - albiet ridiculous and frivolous as they may be
I don't know. scott has these little analyst field things on quote grids that popped up "negative" or was it "avoid"? avoid might have been on another stock i have... ( I for one pay them little mind)... anyway noticed it for IBIO right after the lawsuits came up. People including some possibly lazy analysts may just skim and veer off as soon as they see there is any kind of lawsuit. Also a stock screener would just pick up on "lawsuit", not what kind, and just skip and go on with the next criteria to narrow things down to what to actually look at, out of thousands of stocks to choose from.
I don't know about down. I'm guessing they don't help. But I would expect some up, once they are dropped or dismissed. It will be like taking a weight off.
It is a better link. You get the control panel right away.
This is for the second link she posted...
I found you need to click on the homepage link. Then select the article. Then you get the little control panel at the bottom that lets you zoom. Then you have to click on the tiny page for zoom-in to work so it's big enough to read. The arrow buttons to go to next page etc. It is a little complicated but I got it to work (finally)
good interview article - worth the effort i would say :)
SIMH isn't just Houlihan...
from the 12-31-2013 10k:
Although we have limited funds, our Chief Technology Officer, Gary O’Hara, is coordinating our own research efforts and the efforts of our several consultants. Mr. O’Hara developed the first infrared tympanic (ear) thermometer for the professional market in the mid-1980’s (the product he developed, FirstTemp Genius, is still being sold today, almost 30 years after his company was sold in 1992 to pharmaceutical giant American Home Products (now part of Pfizer)). He is thoroughly familiar with the current sensor and design technologies and the intellectual property landscape. He also has engaged the following consultants to assist our second generation development efforts: A hardware/software designer who supervises our prototype development; and an experienced thermometry clinical scientist with 20 years of clinical thermometry research experience who can perform clinical studies and data analysis on our products under development; and both worked with Mr. O’Hara in developing an ear thermometer. However, we also need to hire qualified engineers to implement the electro-optics design, electronic circuitry and software design necessary for our next generation thermometers.
from bloomberg/businessweek:
Background*
Mr. Gary O'Hara is a Founder of Intelligent Medical Systems, Inc. Mr. O'Hara has been the Chief Technology Officer of Sanomedics International Holdings, Inc. since July 28, 2010. He has over 25 years of experience in medical device product innovation and business development. Prior to his work in the medical device industry, he co-founded Tryom, Inc. which was a developer and manufacturer of handheld personal information devices and electronic games of strategy such as backgammon, chess and contract bridge. Mr. O'Hara serves as Member of Advisory Board at Sanomedics International Holdings, Inc. He invented the first commercialized infrared tympanic thermometer (FirstTemp® and Genius® brands) for which he was cited as Inventor of the Year by the San Diego Patent Law Association. Mr. O’Hara has also been active in the seed and startup phases of many ventures through his involvement with the Tech Coast Angels which is an organization of 150 investors that invest in and mentor early stage technology and biomedical companies. Mr. O’Hara holds numerous patents related to medical devices and electronic computer games and holds B.S. and M.S. degrees in Electrical Engineering from the University of Michigan as well as an MBA from Eastern Michigan University.
http://investing.businessweek.com/research/stocks/people/person.asp?personId=100305020&ticker=SIMH&previousCapId=3018130&previousTitle=SANOMEDICS%20INTERNATIONAL%20HOL
Agreed. Obviously a bottoming pattern. Despite the 0.095 hit below the 0.01 bid in the final minutes, painting the tape. Trades were all around 0.01 after the first hour, including a 1 million share block at 0.0998 at 3:21:05. there were only two trades at 0.095 in the final minutes before the bell. One was 500 shares followed by 20k at 3:57:47. There was actually one more tiny trade 48 secs before the close at 0.102 according to my 1 sec streaming quote chart, but, evidently, it didn't get counted.
The contention that the convertibles are resulting in endless dilution isn't really true. It's a priori not true. The lenders will stop selling when they get their money. It's a finite amount of money. It has an end. SIMH share volume sold over the last month totals 174.51 million shares. Much of them went for more. but let's say @0.01/share. That still comes to $1.74 million. That's just for one month...
Now, with naked shorting, you can sell an endless amount of shares. Market makers do that all the time to create liquidity. The structure of the convertibles means that a lot of shares needed to be sold. Unfortunately, to the short seller(s), getting wind of this, they can jump in and pre-empt the lenders on the ask, forcing the sellers of the convertibles to sell on the bid. As has been remarked previously by another poster, it is not in the best interest of the lenders to drive the pps down by selling too much at a time, because it takes them longer to get their money. On the other hand, selling short shares to longs off the ask and then covering by eventually buying the lender's liquidation shares on the bid, meanwhile scalping the spread, is a bonanza for the short seller. They would prolong the gravy train as long as they can. A lot of the volume unfortunately could be phantom naked short shares being churned back and forth to drive the price down. It would be interesting to ask the sellers of the convertibles, which, at least, are real shares, how many they have actually sold.
I think of that would as the other problem. One being bad talk from the "competition". The other being manipulation of the stock price by artificially flooding in excess shares. In some cases, the same people calling the stock a piece of detritus are likely part and partial or even the same entity driving it down. The endless repetition of negatives provides cover for the manipulation. One would think it would be illegal, it certainly seems unethical, maybe a slight chance of getting slapped if it's too blatant, hence the incentive to blow smoke, deflect blame, emote innuendo. Also, create enough doubt on a speculative stock and it can become a self-fulfilling prophesy. Sometimes it works. Otherwise one wouldn't see so many seemingly endless repetitive attempts at it.
Anyway, to make an educated guess, pretty soon, if not already, all the converted shares required to date will have been sold, and the short selling party winds down.
The Chinese tax on production will help NioCorp indirectly. The only thing is the latter part where it discusses Chinese imports. That is a bit confusing since I thought China was a net exporter. Did it lose something in translation?
re: "2.29 X 105 = 240.45 ("before")
7.66 X 104 = 796.64 ("after") " ...
Looks like scientific notation with lack of a superscript (font limitation)
If so that would be 2.29 times ten to the 5th power (100,000)= 229,000 before and then 7.66 times ten to the 4th power (10,000) = 76,664 after.
That would be a 66% reduction. Two thirds of the virus particles gone. A significant reduction.
The dialysis hookup only diverts a fraction of the circulation so all one could expect would be a reduction in total viral content, even if you removed 100% from that stream. Removing them faster than the remaining infected cells in the body explode out more new copies would then help turn the tide, assuming the immune system is still in the fight. Otherwise, there is probably a point where nothing will help.